Experimental Treatment for Type 1 Diabetes Patients Shows Promise
Key points
- New research monitoring the effects of Islet cell transplantation resulted in near-normal metabolic control and decreased hypoglycemia.
- During the 18 month study, physicians used Continuous Glucose Monitoring Systems to monitor the effects of the islet cell transplant procedure on patients with type 1 diabetes.
- “Our findings suggest that the majority of patients with Type 1 diabetes who have received an islet transplant benefit from near normal metabolic control, with fewer and shorter episodes of hypoglycemia,” said Lisa Gorn, DO, the study’s primary author.
- “These patients also spent longer periods of time in normoglycemia overall.
New research monitoring the effects of Islet cell transplantation resulted in near-normal metabolic control and decreased hypoglycemia. This research will be presented at the American Association of Clinical Endocrinologists (AACE) 17th Annual Meeting & Clinical Congress, on Friday, May 16th, at the Walt Disney World Dolphin Resort in Orlando.
During the 18 month study, physicians used Continuous Glucose Monitoring Systems to monitor the effects of the islet cell transplant procedure on patients with type 1 diabetes. The results were intriguing.
“Our findings suggest that the majority of patients with Type 1 diabetes who have received an islet transplant benefit from near normal metabolic control, with fewer and shorter episodes of hypoglycemia,” said Lisa Gorn, DO, the study’s primary author.
“These patients also spent longer periods of time in normoglycemia overall.
At the 2008 AACE Annual Meeting diabetes will be taking center stage. A special symposium titled “Clinical Trials Targeting Glycemia: What Do We Expect to Learn?” will consider the impact of glucose control through studies including ACCORD, ADVANCE, VADT, and others.
Related sessions of interest include “Insulin Resistance and Atherosclerosis: The Missing Link,” and “Hypoglycemia: The Limiting Factor in the Glycemic Management of Diabetes.”
Source: American Association of Clinical Endocrinologists (AACE)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsArtificial Pancreas Could Revolutionize Treatment of Type 1 Diabetes
Researchers at the University of Virginia and sites across the globe are testing a computerized, subcutaneous system that could one day transform the way Type 1 diabetics manage their disease. UVA investigators have…
27 October 2008
GuideVitamins and Minerals - Medical Nutrition Treatment in the Management of Type 2 Diabetes
Individuals with diabetes should be advised about the importance of acquiring daily vitamin and mineral requirements from natural food sources. Regular consumption of a variety of vegetables, fresh fruit (five or more…
12 September 2008
GuideDietary Protein - Medical Nutrition Treatment in the Management of Type 2 Diabetes
A few studies suggest that persons with type 2 diabetes have an increased need for protein during moderate hyperglycemia, and an altered adaptive mechanism for protein-sparing during weight-loss, resulting in an…
